Osteonecrosis of the Jaw Caused by Denosumab in Treatment-Naïve and Pre-Treatment with Zoledronic Acid Groups: A Time-to-Onset Study Using the Japanese Adverse Drug Event Report (JADER) Database

BACKGROUND: Medication-related osteonecrosis of the jaw is a serious adverse event associated with bone-modifying agents, such as injectable bisphosphonate (zoledronic acid) and the anti-receptor activator of nuclear factor-κB ligand antibody (denosumab). OBJECTIVE: This study aims to evaluate and c...

Descripción completa

Detalles Bibliográficos
Autores principales: Hasegawa, Shiori, Ikesue, Hiroaki, Satake, Riko, Inoue, Misaki, Yoshida, Yu, Tanaka, Mizuki, Matsumoto, Kiyoka, Wakabayashi, Wataru, Oura, Keita, Muroi, Nobuyuki, Hashida, Tohru, Iguchi, Kazuhiro, Nakamura, Mitsuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712889/
https://www.ncbi.nlm.nih.gov/pubmed/35933498
http://dx.doi.org/10.1007/s40801-022-00324-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712889/
https://www.ncbi.nlm.nih.gov/pubmed/35933498
http://dx.doi.org/10.1007/s40801-022-00324-4

Ejemplares similares